JP2014221842A5 - - Google Patents

Download PDF

Info

Publication number
JP2014221842A5
JP2014221842A5 JP2014177733A JP2014177733A JP2014221842A5 JP 2014221842 A5 JP2014221842 A5 JP 2014221842A5 JP 2014177733 A JP2014177733 A JP 2014177733A JP 2014177733 A JP2014177733 A JP 2014177733A JP 2014221842 A5 JP2014221842 A5 JP 2014221842A5
Authority
JP
Japan
Prior art keywords
tetramethylhexadec
trienyl
diene
hydroxy
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014177733A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014221842A (ja
JP6001025B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014221842A publication Critical patent/JP2014221842A/ja
Publication of JP2014221842A5 publication Critical patent/JP2014221842A5/ja
Application granted granted Critical
Publication of JP6001025B2 publication Critical patent/JP6001025B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014177733A 2008-10-28 2014-09-02 α−トコトリエノールおよび誘導体の産生のためのプロセス Active JP6001025B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19758508P 2008-10-28 2008-10-28
US61/197,585 2008-10-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011534678A Division JP5775459B2 (ja) 2008-10-28 2009-10-27 α−トコトリエノールおよび誘導体の産生のためのプロセス

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015140302A Division JP2015187169A (ja) 2008-10-28 2015-07-14 α−トコトリエノールおよび誘導体の産生のためのプロセス

Publications (3)

Publication Number Publication Date
JP2014221842A JP2014221842A (ja) 2014-11-27
JP2014221842A5 true JP2014221842A5 (enExample) 2015-08-27
JP6001025B2 JP6001025B2 (ja) 2016-10-05

Family

ID=42118126

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011534678A Active JP5775459B2 (ja) 2008-10-28 2009-10-27 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2014177733A Active JP6001025B2 (ja) 2008-10-28 2014-09-02 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2015140302A Withdrawn JP2015187169A (ja) 2008-10-28 2015-07-14 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2018108448A Active JP7181708B2 (ja) 2008-10-28 2018-06-06 α-トコトリエノールおよび誘導体の産生のためのプロセス
JP2019008496A Withdrawn JP2019065041A (ja) 2008-10-28 2019-01-22 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2021016310A Withdrawn JP2021066745A (ja) 2008-10-28 2021-02-04 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2023057343A Withdrawn JP2023073469A (ja) 2008-10-28 2023-03-31 α-トコトリエノールおよび誘導体の産生のためのプロセス

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011534678A Active JP5775459B2 (ja) 2008-10-28 2009-10-27 α−トコトリエノールおよび誘導体の産生のためのプロセス

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2015140302A Withdrawn JP2015187169A (ja) 2008-10-28 2015-07-14 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2018108448A Active JP7181708B2 (ja) 2008-10-28 2018-06-06 α-トコトリエノールおよび誘導体の産生のためのプロセス
JP2019008496A Withdrawn JP2019065041A (ja) 2008-10-28 2019-01-22 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2021016310A Withdrawn JP2021066745A (ja) 2008-10-28 2021-02-04 α−トコトリエノールおよび誘導体の産生のためのプロセス
JP2023057343A Withdrawn JP2023073469A (ja) 2008-10-28 2023-03-31 α-トコトリエノールおよび誘導体の産生のためのプロセス

Country Status (17)

Country Link
US (6) US8106223B2 (enExample)
EP (3) EP2963006B1 (enExample)
JP (7) JP5775459B2 (enExample)
CN (2) CN102264730B (enExample)
BR (1) BRPI0920414B1 (enExample)
CA (2) CA2974482C (enExample)
DK (2) DK2362875T3 (enExample)
EA (2) EA201692046A1 (enExample)
ES (2) ES2553557T3 (enExample)
HU (1) HUE041714T2 (enExample)
MX (1) MX2011004440A (enExample)
MY (2) MY185183A (enExample)
PL (2) PL2963006T3 (enExample)
PT (2) PT2362875E (enExample)
SI (1) SI2963006T1 (enExample)
TR (1) TR201819154T4 (enExample)
WO (1) WO2010051277A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580584C (en) 2003-09-19 2015-07-28 Galileo Pharmaceuticals, Inc. Use of alpha-tocotrienol for treatment of mitochondrial diseases
EP2471530B1 (en) * 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
CA2635280C (en) 2006-02-22 2017-12-12 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EA028911B1 (ru) 2007-11-06 2018-01-31 Биоэлектрон Текнолоджи Корпорейшн ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
WO2009089224A1 (en) * 2008-01-08 2009-07-16 Edison Pharmaceuticals, Inc. (HET) ARYL-p-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
EP2262508B1 (en) 2008-03-05 2018-10-03 BioElectron Technology Corporation SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
US8716486B2 (en) * 2008-06-25 2014-05-06 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
EP2362726B1 (en) 2008-10-14 2018-08-08 Bioelectron Technology Corporation Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
PT2362875E (pt) * 2008-10-28 2015-11-03 Edison Pharmaceuticals Inc Processo para a produção de alfa-tocotrienol e seus derivados
MX336800B (es) 2009-04-28 2016-02-02 Edison Pharmaceuticals Inc Tratamiento de neuropatia optica hereditaria de leber y atrofia optica dominante con tocotrienol quinonas.
CN102647981B (zh) 2009-08-26 2016-09-28 爱迪生制药有限公司 预防和治疗脑缺血的方法
WO2012154613A1 (en) * 2011-05-06 2012-11-15 Edison Pharmaceuticals, Inc. Improved process for the preparation of d-alpha-tocotrienol from natural extracts
WO2012174286A1 (en) 2011-06-14 2012-12-20 Edison Pharmaceuticals, Inc. Catechol derivatives for treatment of oxidative stress diseases
CA2842486C (en) 2011-07-19 2022-09-06 Edison Pharmaceuticals, Inc. Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
MY162508A (en) * 2011-07-21 2017-06-15 Sime Darby Malaysia Berhad External preparation for skin
WO2014039917A1 (en) 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Benzoquinone derivatives for treating oxidative stress disorders
US8937191B2 (en) 2012-12-20 2015-01-20 Orochem Technologies, Inc. Recovery of highly pure alpha-tocotrienol from crude palm oil extract
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
HK1220451A1 (zh) 2013-03-15 2017-05-05 Bioelectron Technology Corporation 用於治疗氧化应激障碍的烷基-杂芳基取代醌衍生物
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
CN106414580A (zh) * 2013-11-29 2017-02-15 沙特基础工业公司 稳定化的聚烯烃组合物
US9512098B1 (en) 2014-02-03 2016-12-06 Board Of Trustees Of The University Of Arkansas Process of producing purified gamma- and delta-tocotrienols from tocol-rich oils or distillates
CN104262315A (zh) * 2014-09-05 2015-01-07 宁波大红鹰生物工程股份有限公司 一种生育三烯酚的分离提纯方法
WO2016100579A1 (en) 2014-12-16 2016-06-23 Edison Pharmaceuticals, Inc., Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
JP2018502127A (ja) 2015-01-12 2018-01-25 バイオエレクトロン テクノロジー コーポレイション 放射線被曝に対する防護のためのキノン
JP7117241B2 (ja) * 2015-12-16 2022-08-12 ピーティーシー セラピューティクス, インコーポレイテッド 混合されたトコール組成物からアルファ-トコトリエノールを富化するための改良された方法
CA3008849A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
WO2017123820A1 (en) 2016-01-12 2017-07-20 Bioelectron Technology Corporation Methods for diagnosing and treating oxidative stress disorders using biomarkers
JP2018083799A (ja) 2016-11-15 2018-05-31 バイオエレクトロン テクノロジー コーポレイション 2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩
CA3097114A1 (en) 2017-04-14 2018-10-18 Bioelectron Technology Corporation Methods and compositions for treatment of inflammation and oxidative stress
HUE066196T2 (hu) 2018-10-17 2024-07-28 Ptc Therapeutics Inc 2,3,5-trimetil-6-nonilciklohexa-2,5-dién-1,4-dion alfa-szinukleinopátiák, tauopátiák és egyéb rendellenességek szuppresszálására és kezelésére
AU2020358970A1 (en) 2019-10-04 2022-04-14 Stealth Biotherapeutics Inc. Chinone-, hydrochinome- and naphthochinone-analogues of vatiquione for treatment of mitochondrial disorder diseases
CN115996916B (zh) 2020-04-03 2025-09-23 康德生物医疗有限公司 用于预防和/或治疗包括弗里德赖希共济失调的线粒体疾病的组合物和方法
IL310011A (en) 2021-07-08 2024-03-01 Ptc Therapeutics Inc Pharmaceutical compositions containing 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2519863A (en) 1949-05-14 1950-08-22 Eastman Kodak Co Conversion of beta-, gamma-, and delta-tocopherol to alpha-tocopherol by aminoalkylation and reduction
EP0159018A3 (en) * 1984-04-17 1986-10-01 HENKEL CORPORATION (a Delaware corp.) Production of d-alpha-tocopherol from natural plant sources
US4977282A (en) 1984-04-17 1990-12-11 Henkel Corporation Production of d-alpha-tocopherol from natural plant sources
US4603142A (en) 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
JPS636186A (ja) 1986-06-23 1988-01-12 タツタ電線株式会社 点滴監視装置
JPH0788376B2 (ja) 1986-09-02 1995-09-27 エーザイ株式会社 光学活性α−トコトリエノ−ルの製造方法
JP2685785B2 (ja) 1988-03-11 1997-12-03 エーザイ株式会社 光学活性α−トコトリエノールの製造方法
EP0333472B1 (en) 1988-03-16 1997-10-08 PALM OIL RESEARCH & DEVELOPMENT BOARD Production of high concentration tocopherols and tocotrienols from palm oil by-products
US5157132A (en) * 1990-05-18 1992-10-20 Carotech Associates Integrated process for recovery of carotenoids and tocotrienols from oil
US5591772A (en) 1991-11-22 1997-01-07 Lipogenics, Inc. Tocotrienols and tocotrienol-like compounds and methods for their use
DE59605564D1 (de) * 1995-03-28 2000-08-17 Hoffmann La Roche Aminomethylierung von Tocopherolen
US5660691A (en) 1995-11-13 1997-08-26 Eastman Chemical Company Process for the production of tocotrienol/tocopherol blend concentrates
US6232060B1 (en) 1996-01-19 2001-05-15 Galileo Laboratories, Inc. Assay system for anti-stress agents
US5801159A (en) 1996-02-23 1998-09-01 Galileo Laboratories, Inc. Method and composition for inhibiting cellular irreversible changes due to stress
US5932748A (en) 1997-06-06 1999-08-03 Roche Vitamins Inc. Process for permethylating non-α-tocopherols to produce α-tocopherol
JP4267815B2 (ja) * 1997-10-29 2009-05-27 フレクシス アメリカ エル. ピー. 過酸化水素及び触媒を使用してフェニレンジアミンからキノンジイミンを製造する方法
CN1295568A (zh) 1998-01-29 2001-05-16 伊斯曼化学公司 从含有母育酚的混合物中分离生育三烯酚的方法及其组合物
JP3258003B2 (ja) * 1998-11-06 2002-02-18 富士化学工業株式会社 トコトリエノール類含有粉末、その製造方法およびそれを圧縮成型してなる錠剤
US6395915B1 (en) 1999-09-10 2002-05-28 Technikrom, Inc. Method for producing purified tocotrienols and tocopherols using liquid chromatography
MY127451A (en) 1999-11-04 2006-12-29 Malaysian Palm Oil Board A method of chromatographic isolation for vitamin e isomers
DE10034233A1 (de) * 2000-07-14 2002-01-24 Basf Ag Tocotrienolchinon-Cyclisierungsprodukte
US7034054B2 (en) 2000-12-15 2006-04-25 Galileo Pharmaceuticals, Inc. Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
US6838104B2 (en) 2000-12-20 2005-01-04 Archer Daniels Midland Company Process for the production of tocotrienols
US6608196B2 (en) 2001-05-03 2003-08-19 Galileo Pharmaceuticals, Inc. Process for solid supported synthesis of pyruvate-derived compounds
JP4842455B2 (ja) 2001-06-13 2011-12-21 コマツNtc株式会社 半導体単結晶引上げ装置及びそのライン構成
JP2003171376A (ja) 2001-09-27 2003-06-20 Lion Corp トコフェロール類及びトコトリエノール類濃縮物、その製造方法
US6667330B2 (en) 2002-01-31 2003-12-23 Galileo Pharmaceuticals, Inc. Furanone derivatives
US6653346B1 (en) 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
US6590113B1 (en) 2002-03-26 2003-07-08 Ronald T. Sleeter Process for treating oils containing antioxidant compounds
US7491312B2 (en) 2002-10-30 2009-02-17 Edison Pharmaceuticals, Inc. Identifying therapeutic compounds based on their physical-chemical properties
MY130618A (en) 2002-11-27 2007-07-31 Malaysian Palm Oil Board A method of extracting and isolating minor components from vegetable oil
CA2580584C (en) 2003-09-19 2015-07-28 Galileo Pharmaceuticals, Inc. Use of alpha-tocotrienol for treatment of mitochondrial diseases
WO2005035490A2 (en) 2003-10-10 2005-04-21 Yasoo Health, Inc. PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS
MY173044A (en) 2003-11-19 2019-12-20 Carotech Bhd Recovery of phytonutriens from oils
US7393662B2 (en) 2004-09-03 2008-07-01 Centocor, Inc. Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
EP2471530B1 (en) 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7432305B2 (en) 2005-09-15 2008-10-07 Edison Pharmaceuticals, Inc. Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
CA2635280C (en) 2006-02-22 2017-12-12 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
WO2007105297A1 (ja) * 2006-03-13 2007-09-20 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo メチン系色素とその用途
AU2008205263A1 (en) 2007-01-10 2008-07-17 Edison Pharmaceuticals, Inc. Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
WO2008142433A1 (en) 2007-05-24 2008-11-27 Loders Croklaan B.V. Process for producing compositions comprising tocoherols and tocotrienols
EA028911B1 (ru) 2007-11-06 2018-01-31 Биоэлектрон Текнолоджи Корпорейшн ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
JP2011508777A (ja) 2008-01-07 2011-03-17 セントコア・オーソ・バイオテツク・インコーポレーテツド エリスロポエチン低応答性貧血を治療する方法
WO2009089224A1 (en) 2008-01-08 2009-07-16 Edison Pharmaceuticals, Inc. (HET) ARYL-p-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
WO2009111543A2 (en) * 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. Treatment of hearing and balance impairments with redox-active therapeutics
EP2262508B1 (en) 2008-03-05 2018-10-03 BioElectron Technology Corporation SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
US20110142834A1 (en) 2008-05-15 2011-06-16 Edison Pharmaceuticals, Inc. Treatment of hearing and balance impairments using compounds having erythropoietin activity
US20090291092A1 (en) 2008-05-22 2009-11-26 Miller Guy M Treatment of mitochondrial diseases with an erythropoietin mimetic
US8716486B2 (en) 2008-06-25 2014-05-06 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
WO2010005989A1 (en) 2008-07-09 2010-01-14 Edison Pharmaceuticals, Inc. Dermatological compositions with anti-aging and skin even-toning properties
US20100029784A1 (en) 2008-07-30 2010-02-04 Hinman Andrew W Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
WO2010014758A1 (en) 2008-07-30 2010-02-04 Edison Pharmaceuticals, Inc. Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
EP2362726B1 (en) 2008-10-14 2018-08-08 Bioelectron Technology Corporation Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
PT2362875E (pt) * 2008-10-28 2015-11-03 Edison Pharmaceuticals Inc Processo para a produção de alfa-tocotrienol e seus derivados
MX336800B (es) 2009-04-28 2016-02-02 Edison Pharmaceuticals Inc Tratamiento de neuropatia optica hereditaria de leber y atrofia optica dominante con tocotrienol quinonas.
BRPI1015006A2 (pt) 2009-04-28 2019-09-24 Ampere Life Sciences Inc uso tópico, periocular, ou intraocular de tocotrienóis para o tratamento de doenças oftálmicas
MX2011011310A (es) 2009-04-28 2011-11-18 Edison Pharmaceuticals Inc Formulacion de tocotrienol quinonas para el tratamiento de enfermedades oftalmicas.
JP2012531411A (ja) 2009-06-25 2012-12-10 アンペア ライフ サイエンシーズ,インコーポレイテッド トコトリエノールまたはトコトリエノール濃縮抽出物を用いた広汎性発達障害の処置
CN102647981B (zh) 2009-08-26 2016-09-28 爱迪生制药有限公司 预防和治疗脑缺血的方法
WO2011082355A1 (en) 2009-12-31 2011-07-07 Edison Pharmaceuticals, Inc. Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
AU2011224411A1 (en) 2010-03-09 2012-10-18 Penwest Pharmaceuticals Co. Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same
WO2011113018A1 (en) 2010-03-12 2011-09-15 Ampere Life Sciences, Inc. Measurement and control of biological time
US20130116336A1 (en) 2010-04-06 2013-05-09 William D. Shrader Treatment of ataxia telangiectasia
SG185046A1 (en) 2010-04-27 2012-12-28 Edison Pharmaceuticals Inc Formulations of quinones for the treatment of ophthalmic diseases
WO2012009271A1 (en) 2010-07-14 2012-01-19 Penwest Pharmaceuticals Co. Methods of providing anticoagulation effects in subjects
CA2807507A1 (en) 2010-08-06 2012-02-09 Edison Pharmaceuticals, Inc. Treatment of mitochondrial diseases with naphthoquinones
WO2012068552A1 (en) 2010-11-19 2012-05-24 Edison Pharmaceuticals, Inc. Methods for improving blood glucose control
WO2012154613A1 (en) 2011-05-06 2012-11-15 Edison Pharmaceuticals, Inc. Improved process for the preparation of d-alpha-tocotrienol from natural extracts
WO2012170773A1 (en) 2011-06-08 2012-12-13 Edison Pharmaceuticals, Inc. Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
WO2012174286A1 (en) 2011-06-14 2012-12-20 Edison Pharmaceuticals, Inc. Catechol derivatives for treatment of oxidative stress diseases
WO2013006736A1 (en) 2011-07-06 2013-01-10 Edison Pharmaceuticals, Inc Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
ES2795798T3 (es) 2011-07-06 2020-11-24 Ptc Therapeutics Inc Tratamiento de aciduria metilmalónica, aciduria isovalérica, y otras acidurias orgánicas con tocotrienol quinonas
CA2842486C (en) 2011-07-19 2022-09-06 Edison Pharmaceuticals, Inc. Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
WO2014039917A1 (en) 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Benzoquinone derivatives for treating oxidative stress disorders
US8937191B2 (en) 2012-12-20 2015-01-20 Orochem Technologies, Inc. Recovery of highly pure alpha-tocotrienol from crude palm oil extract
CA2902506C (en) 2013-03-08 2024-11-19 Unilever Global Ip Limited Resorcinol compounds for dermatological use
US20140275045A1 (en) 2013-03-15 2014-09-18 Edison Pharmaceuticals, Inc. Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
HK1220451A1 (zh) 2013-03-15 2017-05-05 Bioelectron Technology Corporation 用於治疗氧化应激障碍的烷基-杂芳基取代醌衍生物
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
JP2016520621A (ja) 2013-05-31 2016-07-14 エジソン ファーマシューティカルズ, インコーポレイテッド 酸化ストレス障害の処置のためのカルボン酸誘導体
WO2016100579A1 (en) 2014-12-16 2016-06-23 Edison Pharmaceuticals, Inc., Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
WO2016100576A1 (en) 2014-12-16 2016-06-23 Edison Pharmaceuticals, Inc. Methods for chiral resolution of trolox
JP2018502127A (ja) 2015-01-12 2018-01-25 バイオエレクトロン テクノロジー コーポレイション 放射線被曝に対する防護のためのキノン
JP7117241B2 (ja) 2015-12-16 2022-08-12 ピーティーシー セラピューティクス, インコーポレイテッド 混合されたトコール組成物からアルファ-トコトリエノールを富化するための改良された方法
CA3008849A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
WO2017123823A1 (en) 2016-01-12 2017-07-20 Bioelectron Technology Corporation Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
WO2017123820A1 (en) 2016-01-12 2017-07-20 Bioelectron Technology Corporation Methods for diagnosing and treating oxidative stress disorders using biomarkers
WO2018081644A1 (en) 2016-10-28 2018-05-03 Bioelectron Technology Corporation Methods of analyzing p-hydroquinone levels and ratios
WO2018093957A1 (en) 2016-11-15 2018-05-24 Bioelectron Technology Corporation 2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications
WO2018129411A1 (en) 2017-01-06 2018-07-12 Bioelectron Technology Corporation Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
CA3097114A1 (en) 2017-04-14 2018-10-18 Bioelectron Technology Corporation Methods and compositions for treatment of inflammation and oxidative stress

Similar Documents

Publication Publication Date Title
JP2014221842A5 (enExample)
JP2015063536A5 (enExample)
JP2016520672A5 (enExample)
JP2011105738A5 (enExample)
JP2016153424A5 (enExample)
JP2015522045A5 (enExample)
JP2016139345A5 (enExample)
WO2015187774A8 (en) 3,6-dichlorosalicylic acid compounds and related synthetic processes
RU2013120972A (ru) Гидроксид магния с высоким соотношением размеров кристаллов
JP2013234106A5 (enExample)
JP2013543297A5 (enExample)
JP2016532706A5 (enExample)
JP2013532130A5 (enExample)
JP2014122247A5 (ja) β−クリプトキサンチンを有効成分とするペルオキシソーム増殖剤応答性受容体(PPAR)の活性化剤
JP2012122069A5 (enExample)
JP2018030858A5 (enExample)
JP2017502134A5 (enExample)
WO2016092561A3 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
JP2017500407A5 (enExample)
JP2016530227A5 (enExample)
JP2017505336A5 (enExample)
WO2016142819A3 (en) Novel process for the preparation of ranolazine
JP2017061668A5 (enExample)
JP2016516014A5 (enExample)
JP2016535096A5 (enExample)